stocks logo

NNVC Valuation

NanoViricides Inc
$
1.530
+0.03(2.000%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

NNVC Relative Valuation

NNVC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NNVC is overvalued; if below, it's undervalued.
AI Stock Picker

Historical Valuation

NanoViricides Inc (NNVC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.69. The fair price of NanoViricides Inc (NNVC) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:1.53
Fair
-2.63
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
NanoViricides Inc. (NNVC) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -4.39. The thresholds are as follows: Strongly Undervalued below -28.79, Undervalued between -28.79 and -16.59, Fairly Valued between 7.82 and -16.59, Overvalued between 7.82 and 20.02, and Strongly Overvalued above 20.02. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-2.16
EV/EBIT
NanoViricides Inc. (NNVC) has a current EV/EBIT of -2.16. The 5-year average EV/EBIT is -1.42. The thresholds are as follows: Strongly Undervalued below -3.25, Undervalued between -3.25 and -2.34, Fairly Valued between -0.50 and -2.34, Overvalued between -0.50 and 0.42, and Strongly Overvalued above 0.42. The current Forward EV/EBIT of -2.16 falls within the Historic Trend Line -Fairly Valued range.
0.00
PS
NanoViricides Inc. (NNVC) has a current PS of 0.00. The 5-year average PS is 0.35. The thresholds are as follows: Strongly Undervalued below -1.76, Undervalued between -1.76 and -0.70, Fairly Valued between 1.41 and -0.70, Overvalued between 1.41 and 2.47, and Strongly Overvalued above 2.47. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-2.67
P/OCF
NanoViricides Inc. (NNVC) has a current P/OCF of -2.67. The 5-year average P/OCF is -3.12. The thresholds are as follows: Strongly Undervalued below -7.17, Undervalued between -7.17 and -5.15, Fairly Valued between -1.09 and -5.15, Overvalued between -1.09 and 0.93, and Strongly Overvalued above 0.93. The current Forward P/OCF of -2.67 falls within the Historic Trend Line -Fairly Valued range.
-2.77
P/FCF
NanoViricides Inc. (NNVC) has a current P/FCF of -2.77. The 5-year average P/FCF is -2.83. The thresholds are as follows: Strongly Undervalued below -6.90, Undervalued between -6.90 and -4.86, Fairly Valued between -0.80 and -4.86, Overvalued between -0.80 and 1.24, and Strongly Overvalued above 1.24. The current Forward P/FCF of -2.77 falls within the Historic Trend Line -Fairly Valued range.
NanoViricides Inc (NNVC) has a current Price-to-Book (P/B) ratio of 2.73. Compared to its 3-year average P/B ratio of 1.48 , the current P/B ratio is approximately 84.38% higher. Relative to its 5-year average P/B ratio of 1.45, the current P/B ratio is about 87.95% higher. NanoViricides Inc (NNVC) has a Forward Free Cash Flow (FCF) yield of approximately -34.86%. Compared to its 3-year average FCF yield of -38.04%, the current FCF yield is approximately -8.38% lower. Relative to its 5-year average FCF yield of -31.11% , the current FCF yield is about 12.04% lower.
2.73
P/B
Median3y
1.48
Median5y
1.45
-34.86
FCF Yield
Median3y
-38.04
Median5y
-31.11
Financial AI Agent

Competitors Valuation Multiple

The average P/S ratio for NNVC's competitors is 105.55, providing a benchmark for relative valuation. NanoViricides Inc Corp (NNVC) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Intellectia AI SwingMax

Performance Decomposition

1Y
3Y
5Y
Market capitalization of NNVC increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of NNVC in the past 1 year is driven by Unknown.

FAQ

arrow icon

Is NanoViricides Inc (NNVC) currently overvalued or undervalued?

NanoViricides Inc (NNVC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.69. The fair price of NanoViricides Inc (NNVC) is between NaN to NaN according to relative valuation methord.
arrow icon

What is NanoViricides Inc (NNVC) fair value?

arrow icon

How does NNVC's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for NanoViricides Inc (NNVC) as of Aug 19 2025?

arrow icon

What is the current FCF Yield for NanoViricides Inc (NNVC) as of Aug 19 2025?

arrow icon

What is the current Forward P/E ratio for NanoViricides Inc (NNVC) as of Aug 19 2025?

arrow icon

What is the current Forward P/S ratio for NanoViricides Inc (NNVC) as of Aug 19 2025?